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Abstract
Invariant natural killer T (iNKT) cells are an evolutionary conserved T cell population characterized by features of both the
innate and adaptive immune response. Studies have shown that iNKT cells are required for protective responses to Gram-
positive pathogens such as Streptococcus pneumoniae, and that these cells recognize bacterial diacylglycerol antigens
presented by CD1d, a non-classical antigen-presenting molecule. The combination of a lipid backbone containing an
unusual fatty acid, vaccenic acid, as well as a glucose sugar that is weaker or not stimulatory when linked to other lipids, is
required for iNKT cell stimulation by these antigens. Here we have carried out structural and biophysical studies that
illuminate the reasons for the stringent requirement for this unique combination. The data indicate that vaccenic acid
bound to the CD1d groove orients the protruding glucose sugar for TCR recognition, and it allows for an additional
hydrogen bond of the glucose with CD1d when in complex with the TCR. Furthermore, TCR binding causes an induced fit in
both the sugar and CD1d, and we have identified the CD1d amino acids important for iNKT TCR recognition and the stability
of the ternary complex. The studies show also how hydrogen bonds formed by the glucose sugar can account for the
distinct binding kinetics of the TCR for this CD1d-glycolipid complex. Therefore, our studies illuminate the mechanism of
glycolipid recognition for antigens from important pathogens.
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Introduction
Invariant NKT cells (iNKT) are an evolutionarily conserved
population of T lymphocytes able to respond to lipid antigens
when presented by CD1d, a non-classical MHC class I–like
molecule [1].
Antigen recognition by iNKT cells is mediated by a semi-
invariant ab T cell receptor (TCR) formed by a conserved Va14-
Ja18 rearrangement (Va24-Va18 in humans), and a limited panel
of pairing b chains (Vb8.2, Vb7, Vb2 in mouse; Vb11 in humans).
The number of antigens recognized by these cells has increased in
the last few years, following the discovery of a-galactosylceramide
(a-GalCer), the prototypical iNKT antigen [2]. Although the
nature of the predominant self-antigens recognized by iNKT cells
still remains controversial, important progress has been made in
describing the microbial antigens recognized by this cell type.
Glycosphingolipids from Sphingomonas spp. and diacylglycerol
(DAG) ligands from Borrelia burgdorferi, the causative agent of
Lyme disease, were identified to stimulate iNKT cells in a CD1d/
TCR-dependent manner [3–7]. As Sphingomonas spp. and B.
burgdorferi are not responsible for widespread or lethal diseases, we
considered it possible that more pathogenic organisms also express
iNKT antigens, which would account for the highly conserved
nature of the CD1d-iNKT TCR interaction. Indeed, recent
studies identified the structures of DAG compounds from the
highly pathogenic Streptococcus pneumoniae (S. pneumoniae) and Group B
streptococcus (GBS), which were able to stimulate iNKT cells [8]. In
vitro and in vivo assays demonstrated surprisingly strict require-
ments for these antigens in activating iNKT cells. The most potent
S. pneumoniae antigen, Glc-DAG-s2, is characterized by having a sn-
PLoS Biology | www.plosbiology.org 1 November 2011 | Volume 9 | Issue 11 | e10011893 linked glucose, a sn-1 linked palmitic acid (C16:0), and most
importantly, the presence of cis-vaccenic acid (C18:1, n-7) in
position sn-2 of the glycerol moiety. This uncommon fatty acid was
required for significant activity, since the positional isomer with a
vaccenic acid in position sn-1 failed to elicit a strong activation, as
did the homologous compounds containing an oleic acid (C18:1,
n-9). Moreover, the same antigen showed the ability to stimulate
both mouse and human iNKT cells, unlike the previously
characterized DAG antigens from B. burgdorferi [6]. Interestingly,
previous studies showed that glucose-containing glycolipids are
relatively weaker antigens compared to the one containing
galactose or galacturonic acid [2,3,9,10], while the glucose isomer
of the B. burgdorferi glycolipid 2c (BbGL-2c) is not antigenic at all
[6]. It is therefore surprising that the glucose-containing S.
pneumoniae Glc-DAG-s2 is such a potent antigen in eliciting iNKT
cell responses.
In order to determine the molecular basis for the stringent
structural requirements for recognition of the S. pneumoniae antigen
Glc-DAG-s2, and to further analyze the mechanism of the mouse
CD1d (mCD1d)-iNKT TCR complex formation, we determined
the structure of the mCD1d-Glc-DAG-s2-iNKT TCR complex by
X-ray crystallography and we analyzed the role of the F9 roof in
the formation and stability of mCD1d-iNKT TCR complexes.
Our data show how the combination of cis-vaccenic acid and
glucose is required for the formation of novel protein-antigen
contacts, resulting in the relatively strong affinity of this ligand for
the iNKT TCR.
Results
mCD1d-Glc-DAG-s2-TCR Structure
Previous biophysical analysis of the kinetics of interaction of the
mCD1d-Glc-DAG-s2 complex with the iNKT TCR revealed a
TCR interaction with a low micromolar affinity [8]. Overall, Glc-
DAG-s2 complexes with mouse CD1d are characterized by a
comparable but slightly higher affinity for the iNKT TCR
compared to those containing the other known bacterial DAG
antigen BbGL-2c (KD of 4.4 and 6.2 mM, respectively), consistent
with the similar antigenic potencies of these compounds [8,11].
However, complexes containing Glc-DAG-s2 have significantly
different binding kinetics compared to those containing BbGL-2c,
with Glc-DAG-s2 showing considerably slower association and
dissociation rates. In order to investigate the molecular basis for
this different kinetic behavior and the role of the unique structural
features of this ligand in determining its antigenicity, we
determined the crystal structure of the mCD1d-Glc-DAG-s2-
iNKT TCR complex at 2.7 A ˚ resolution (Figure 1, Table 1).
The structure shows the conserved ‘‘parallel" docking mode of
the iNKT TCR on the CD1d-ligand complex (Figure1A) [12–14].
As a consequence of this unique binding mode, the TCR a chain
mediates the majority of the contacts with the CD1d-Glc-DAG-s2
complex, with additional contacts with CD1d provided by the
CDR2b, CDR3b, and, to a lesser extent, the CDR1b loops (Table
S1). Well-defined, unbiased density was present for the ligand,
superior to what has been observed for the mCD1d-Glc-DAG-s2
complex in absence of the TCR [8], suggesting that the ligand
adopts a more rigid and ordered conformation upon TCR binding
(Figure 1B, Figure S1). Similar to the antigens previously
characterized, the TCR CDR1a and CDR3a loops exclusively
mediate contacts between the TCR and the antigen (Figure 2A).
In particular, the TCR recognizes the 29-OH and 39-OH positions
of the hexose ring via H bonds with Gly96 and Asn30 on the a
chain, highlighting the importance of these two hydroxyl groups
on the antigen in the formation of the complex. However, due to
the presence of a glucose on Glc-DAG-s2, the 49 hydroxyl group is
no longer able to interact with Asn30 on the a chain, in contrast to
other galactose-containing glycolipids. Previous studies showed
that the contacts between the ligand and the iNKT dominate the
initial association phase of the interaction [9]. The loss of an H
bond at the ligand-TCR interface, although not sufficient to
Figure 1. Structure of the mCD1d-Glc-DAG-s2-TCR complex. (A)
Cartoon representation of the mCD1d-Glc-DAG-s2-TCR trimolecular
complex with the CD1d/b2m protein in grey, and the TCR a and b
chains in cyan and orange, respectively. The Glc-DAG-s2 antigen is
shown as yellow sticks, tucked at the interface between CD1d and the
TCR. (B) Side-view of the antigen-binding groove in the mCD1d-Glc-
DAG-s2-TCR complex with the DAG antigen shown in sticks and the a2
helix removed for clarity. The 2Fo2Fc electron density map is
contoured at 1s and shown as a blue mesh around the glycolipid
ligand. Several mCD1d residues interacting with the lipid are depicted.
(C) Chemical structure of the Glc-DAG-s2 antigen with vaccenic acid in
the sn-2 position.
doi:10.1371/journal.pbio.1001189.g001
Author Summary
Invariant natural killer T (iNKT) cells are an evolutionarily
conserved population of immune cells that recognize lipid
antigens. A protein called a T cell receptor for antigen
(TCR) on the surface of these iNKT cells recognizes lipids
bound to a protein called CD1d on the surface of antigen-
presenting cells. Here we describe the three-dimensional
structure of the complex that forms between CD1d and
the iNKT TCR together with a glycolipid antigen from the
infectious bacterium Streptococcus pneumoniae, which is a
common cause of bacterial meningitis in adults and is
responsible for many other pneumococcal infections. We
determined the three-dimensional structure of the com-
plex by X-ray crystallography. The data obtained allow us
to understand the structural requirements that make this
glycolipid a potent antigen for iNKT cells, and why the TCR
of these cells recognizes a particular combination of
hexose sugar and diacylglycerol lipid. Moreover, by
mutating CD1d and using biophysical methods to study
the mutant protein complexes, we analyzed the role of the
protein–protein interface between CD1d and the TCR and
found that it plays an important role in the stability, but
not the formation, of the trimolecular complex containing
glycolipid antigen.
iNKT Cell Recognition of Pneumococcal Antigens
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s2 complex, is therefore likely to decrease the association rate.
Induced Fit of the Glycolipid upon TCR Binding
When the structures of the mCD1d-Glc-DAG-s2 complex in the
presence or absence of the TCR are compared, important
conformational changes are observed for the ligand (Figure 2B).
Consistent with what was observed for the mCD1d-Glc-DAG-s2
structure in the absence of the TCR [8], the sn-2 vaccenic acid is
bound in the A9 pocket while the sn-1 palmitic acid occupies the F9
pocket.However, whileintheabsenceofthe TCRthe vaccenic acid
encircles the A9 pole in a clockwise manner,the opposite orientation
is preferred in the ternary complex, although residual density also
suggests some equilibrium between the two orientations. Moreover,
upon TCR ligation, the glucose moiety is shifted by about 30
degrees clockwise around its glycosidic bond to assume a position at
the center of the binding groove as observed for other TCR-bound
glycolipid antigens (Figure 2B). Similar to what has been described
for BbGL-2c, this conformational change requires the breaking of
several contacts with CD1d and the formation of new hydrogen
bonds with the a2 helix of CD1d and the TCR a chain. In
particular, a hydrogen bond with Arg79 on the a1 helix is lost while
new polar contacts are formed with Asp153 and Thr156 on the a2
helix upon TCR binding, resulting in a final orientation conserved
among a-linked sugars [13–15]. As proposed for BbGL-2c, these
conformational changes likely contribute to the slower association
rate of the TCR when binding DAG microbial antigen-mCD1d
complexes compared to sphingolipid-containing antigens [14].
However, the presence of glucose on Glc-DAG-s2 results in an
additional H bond between the antigen and the backbone of the a2
helix of CD1d, involving the carbonyl group of glycine 155 (3.2 A ˚,
Figure 2B). Because this contact stabilizes a favorable binding
conformation of the antigen in the binding groove, it is likely that
this feature is contributing to the slower complex dissociation
observed for this ligand compared to BbGL-2c, as the TCR has to
invest less energy to lock the glucose into place. Moreover,
comparison of the mCD1d-TCR molecular contacts in the two
DAG antigens ternary complexes revealed a slightly optimized
interface for Glc-DAG-s2 compared to BbGL-2c (involving in
particular additional salt bridges between CDR3a and CDR2b
residues with mCD1d; Table S1; [14]), which could have a further
stabilizing effect on the dissociation rate of the ternary complex.
Table 1. Data collection and refinement.
Statistics mCD1d-Glc-DAG-s2-TCR
Data collection
Space group C2221
Cell dimension
a, b, c, (A ˚) 78.1, 190.7, 150.9
a, b, c (u) 90.0, 90.0, 90.0
Resolution range (A ˚) [outer shell] 44.5–2.70 [2.85–2.70]
No. reflections 31,376
Rmerge (%) 13.5 [53.0]
Rpim (%) 7.5 [30.0]
Rmeas (%) 15.5 [61.2]
Multiplicity 4.0 [4.0]
Average I/sI 7.1 [2.4]
Completeness (%) 99.8 [99.9]
Refinement statistics
No. atoms 6,554
Protein 6,276
Ligand 53
Carbohydrate 80
Waters 145
R/Rfree 0.203/0.257
Ramachandran plot (%)
Favored 97.1
Allowed 100.0
R.m.s. deviations
Bonds (A ˚) 0.010
Angles (u) 1.275
B-factors (A ˚2)
Protein 37.4
Ligand 44.6
Carbohydrate 57.3
Waters 30.4
doi:10.1371/journal.pbio.1001189.t001
Figure 2. Binding of Glc-DAG-s2 to mCD1d and the TCR. (A) Contacts between Glc-DAG-s2 and the iNKT TCR. The conserved hydrogen bonds,
involving key residues on CDR1a and CDR3a of the TCR, are shown as dashed blue lines. Glc-DAG-s2, yellow; mCD1d heavy chain, grey; TCR a chain,
cyan; TCR b chain, orange. Top (B) view of the mCD1d interactions with Glc-DAG-s2 in the presence (grey, Glc-DAG-s2 in yellow) or absence (dark
grey, Glc-DAG-s2 in cyan) of the TCR. Hydrogen bond interactions between mCD1d residues and the polar moieties of Glc-DAG-s2 are indicated with
blue dashed lines for the ternary complex and cyan for the mCD1d-Glc-DAG-s2 complex.
doi:10.1371/journal.pbio.1001189.g002
iNKT Cell Recognition of Pneumococcal Antigens
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Antigenicity
When the structures of the ternary complexes of the DAG
antigens Glc-DAG-s2 and BbGL-2c are compared (Figure 3), it is
interesting to note how the unsaturations present on the respective
vaccenic and oleic acids are localized in the same portion of the
mCD1d A9 pocket, suggesting a preference for this region of the
groove for binding unsaturated alkyl chains. Consistent with this, it
was previously noted that the presence of unsaturations improved
the stability of the mCD1d-glycolipid complex, possibly due to the
kink introduced in the alkyl chain by the unsaturated bonds, which
could nicely sit at the bottom of the channel connecting the A9
pocket with the protein surface [16,17]. Assuming that an
unsaturated fatty acid would preferentially bind in the A9 pocket,
in the positional isomer of Glc-DAG-s2 having the vaccenic acid at
the sn-1 position, this would result in a reversed orientation of the
glycerol backbone in the binding groove. The reversed glycerol
orientation would cause an unfavorable positioning of the glucose
head, therefore explaining the lack of antigenic activity for this
compound [8].
A superposition of the mCD1d-Glc-DAG-s2 and mCD1d-
BbGL-2c complexes in presence of the TCR shows how the two
hexose groups are oriented slightly differently at the opening of the
binding groove (Figure 3A). The lack of activity of the Glc-DAG-
s2 analog containing an oleic acid in place of vaccenic acid
suggests that the vaccenic acid is required for a more favorable
orientation of the exposed glucose, possibly enhancing the ability
of the glucose moiety to contact Gly155 and therefore positioning
it in a more stable fashion in the correct orientation for TCR
recognition. Galactose and glucose differ only with regard to the
orientation of the 49 hydroxyl on the hexose sugar ring, with the
axial orientation for galactose and the equatorial orientation, i.e.,
closer to the plane of the ring, for glucose. Despite the structural
similarity of the two sugars, intriguingly, the galactose-containing
version of the S. pneumoniae DAG glycolipid antigen with a sn-2
vaccenic acid, called Gal-DAG-s2, was not able to activate mouse
iNKT cell hybridomas (Figure 4). A drastically reduced response
was also observed for the Gal-DAG-s1 ligand. This indicates that
the presence of vaccenic acid in the A9 pocket of the mCD1d
binding groove does not automatically confer antigenicity. When
the stereochemistry of the 49 carbon is inverted, converting the
glucose of Glc-DAG-s2 into galactose, it becomes clear that the 49-
OH group will be too distant (4.3 A ˚, Figure S2) to engage Asn30
on the CDR3a loop, while at the same time losing the contact with
Gly155 on the a2 helix of mCD1d. Even if a further reorientation
of the galactose sugar by the iNKT TCR were possible, this would
require an additional energetic toll, suggesting a rationale for the
reduced activity of the Gal-DAG-s2 compound. It is therefore
evident that the combination of the uncommon vaccenic acid and
the glucose sugar, which is relatively weak in the context of other
DAG antigens and glycosphingolipids, is required for the optimal
positioning of the Glc-DAG-s2 antigen in the mCD1d binding
groove for TCR recognition.
The mCD1d F9 Roof Affects Recognition by the iNKT TCR
The structures of the iNKT cell TCR in complex with different
mCD1d-microbial antigens complexes showed how the iNKT
TCR is able to induce conformational changes in both the ligand
and mCD1d upon complex formation [14]. In particular, the
insertion of amino acid Leu99a, located on the CDR3a loop of the
iNKT TCR, between residues Leu84, Val149, and Leu150 above
the F9 pocket of mCD1d, resulted in several new van der Waals
(VdW) contacts and the formation of a hydrophobic surface above
the pocket (F9 roof). Consistent with this, a comparison of mCD1d-
Glc-DAG-s2 structures before and after TCR binding reveals that
the F9 roof also is formed for this antigen upon TCR binding
(Figure 5A).
In order to understand and validate the role of the F9 roof in the
formation of a more stable CD1d-Glc-DAG-s2-TCR complex, we
mutated selected residues involved in the formation of the roof and
characterized the ability of the mutated mCD1d proteins to
stimulate iNKT cell hybridomas. As a complete removal of the F9
roof would likely result in an abrogation of binding, as
demonstrated by the loss of function mutation of L99a in the
TCR to alanine [18], we chose mutations of the relevant position
in mCD1d that would maintain the hydrophobic nature of their
side chains, in order to perturb the F9 roof area without making a
too drastic change. We therefore used site-directed mutagenesis to
generate the following mCD1d substitutions: Leu84Val,
Leu84Phe, the latter mimicking the human homolog, Val149Leu
and Leu150Val, together with two control mutants, Met69Ala and
Met162Ala from the area above the A9 pocket (Figure 5A).
Interestingly, we obtained drastically reduced expression yields for
the Leu84Val mutant, and this construct was not tested further.
The iNKT cell hybridomas Hy2C12 (bearing the Va14Vb8.2
TCR used in our structural studies), Hy1.2 (also Va14Vb8.2), and
Hy1.4 (expressing a less common Va14Vb10 TCR) were tested
for their ability to respond to mCD1d-glycolipid complexes in an
Figure 3. Binding of Glc-DAG-s2 and BbGL-2c to mCD1d. Top (A) and side (B) view of the mCD1d interactions in the presence of the TCR. Glc-
DAG-s2 is shown in yellow and BbGL-2c in blue and thin lines with the respective CD1d structure in grey and blue. The novel hydrogen bond formed
between G155 on the a2 helix and the 49-OH of Glc-DAG-s2 is indicated with a blue dashed line with its distance expressed in A ˚. The unsaturations in
the alkyl chains are shown in green and sit in a similar region of the A9 pocket.
doi:10.1371/journal.pbio.1001189.g003
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PLoS Biology | www.plosbiology.org 4 November 2011 | Volume 9 | Issue 11 | e1001189Figure 4. Stringent specificity requirements for recognition of the S. pneumoniae iNKT antigens. (A) Chemical structure of bacterial
antigens BbGL-2c and Glc-DAG-s2 together with galactose-containing versions of Glc-DAG-s2. The 49 hydroxyl group, which differs in orientation
between glucose and galactose and the unsaturations of the antigens, is shown in red. (B) Antigen presenting cells expressing mCD1d were pulsed
with the indicated amounts of each compound and were then cultured with iNKT cell hybridoma 1.2. IL-2 amounts in the culture supernatant are
shown. The error bars indicate the SEM of triplicate measurements and the data are representative of four separate experiments. Due to their
relatively strong response, BbGL-2c and Glc-DAG-s2 were tested exclusively at 10 mg/ml.
doi:10.1371/journal.pbio.1001189.g004
Figure 5. Antigen presentation by F9 roof mutants. (A) Surface of the mCD1d-Glc-DAG-s2 structure in the presence (grey, Glc-DAG-s2 in yellow)
of the iNKT TCR. The residues mutated for further analysis are shown in blue. (B) Relative antigen loading efficiencies by the mCD1d mutants as
determined by surface plasmon resonance. Values are expressed as percentages with the WT protein set at 100%. The ability of CD1d mutants to
present Glc-DAG-s2 (C) and a-GalCer (D) was analyzed in a cell free antigen presentation assay using CD1d coated plates and the Va14i NKT cell
hybridomas Hy2C12, Hy1.2, Hy1.4. As a measure of direct iNKT cell activation IL-2 was measured in the culture supernatant by ELISA. Each bar shows
mean + SD from duplicate wells and is representative of two independent experiments.
doi:10.1371/journal.pbio.1001189.g005
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2 secretion provided a measure of TCR stimulation. We
stimulated the cells with either Glc-DAG-s2 or a-GalCer, the
prototypical iNKT cell antigen that induces a preformed F9 roof
on mCD1d [19]. When loaded with Glc-DAG-s2 or a-GalCer, all
the mutants showed a reduced ability to stimulate the hybridoma
(Figure 5). In particular, the mutants Leu84Phe and Val149Leu
abrogated iNKT cell activation, while a slightly reduced activity
was observed with the Leu150Val mutant.
As the reduced response could be the consequence of impaired
loading of these antigens on mCD1d, we measured the loading
efficiency of a-GalCer on each mutant by surface plasmon
resonance (SPR) using a monoclonal antibody (L363 [20])
specifically reactive to complexes of mCD1d with a-GalCer and
analogs (Figure 5B). Although the Leu84Phe and Met62Ala
mutants showed lower levels of antigen loading compared to wild
type mCD1d, loading on the mutated mCD1d proteins was never
below 65% of the wild type control, and does not appear to
correlate directly with the ability of the mutated proteins to
stimulate the iNKT cell hybridoma. Although the lack of an
antibody able to recognize the mCD1d-Glc-DAG-s2 complex did
not allow us to assess the loading of this antigen onto the mCD1d
mutants, we believe it is unlikely that the two ligands have radically
different loading efficiencies, suggesting a critical role of the area
above the F9 pocket in the TCR interaction with mCD1d/Glc-
DAG-s2 and mCD1d/a-GalCer.
Mutation of F9 Roof Residues Affects Preferentially the
Stability of the mCD1d-iNKT TCR Complex
We previously hypothesized that the formation of the F9 roof on
CD1d affects the stability of the CD1d interaction with the iNKT
TCR [14]. To validate this hypothesis we measured the effect of
the F9 roof mutants on the binding kinetics of the mCD1d-iNKT
TCR complex (Figure 6). Because of the relatively weak
antigenicity of Glc-DAG-s2 compared to a-GalCer, the latter
was chosen for SPR analysis. A comparison of the affinities shows
how all the F9 roof mutants have weaker affinities for the iNKT
TCR, Leu84Phe being the weakest with a ,4-fold reduction
compared to the wild type protein (Figure 6) while the two control
mutants showed affinities and kinetics similar to the wild type
protein. Strikingly, the differences in affinities between mCD1d F9
roof variants derive mainly from faster dissociation rates for the
mutant complexes, while the association rates are minimally
affected by perturbation of the F9 roof. Mutation of residues
Val149 and L150 appear less disruptive than mutation of Leu84,
as the Leu84Phe has the fastest dissociation rate. Taken together,
these data suggest that the F9 roof is critical in determining the
dissociation rate and therefore the stability of the mCD1d-TCR
complex.
Discussion
Activation of iNKT cells can result as a consequence of TCR-
independent, IL12-dependent signals and/or through the recog-
nition of self and foreign antigens by its semi-invariant TCR, with
the latter mechanism playing an important role in modulating the
overall response [21]. The recent discovery that highly pathogenic
Gram-positive bacteria express antigens recognized by both mouse
and human iNKT cells [8] therefore opens important perspectives
for the development of therapeutic agents against pneumonia and
meningitis, while also suggesting a potential rationale for the
conserved features of the CD1d-TCR interaction among different
mammalian species.
Surprisingly, the S. pneumoniae Glc-DAG-s2 antigen presents
unusual chemical features in both its lipidic and polar portions
when compared to the previously characterized iNKT cell
microbial antigens from Sphingomonas spp. or Borrelia burgdorferi.
Instead of the a-galactose or a-galacturonic acid found on these
antigens, and on the prototypical antigen a-GalCer, the otherwise
weaker a-glucose is found in S. pneumoniae as well as in another
gram-positive pathogen, GBS. Furthermore, the sugar is a-linked
to a DAG backbone containing on position sn-2 the uncommon
cis-vaccenic acid. Despite containing a glucose sugar, Glc-DAG-s2
was at least as active as the Borrelia BbGL-2c lipid in activating a
mouse iNKT cell hybridoma and it showed similar antigenic
potency in vivo (Figure 4B; [8]). Interestingly, we show here and in
the previous studies that these unusual features are required
together for the glycosylated DAG lipid to have any measurable
antigenic potency. These stringent requirements were correlated
with unusual binding kinetics compared to the B. burgdorferi DAG
antigens, characterized by slow association and slow dissociation
rates of the mCD1d-ligand complex to the iNKT TCR [8]. The
structure of the mCD1d-Glc-DAG-s2-TCR complex presented
here, together with the other studies we have carried out, allow us
to understand the stringent chemical requirements, as well as the
distinct TCR binding kinetics, in the recognition of the DAG
antigens from these highly pathogenic bacteria.
Figure 6. F9 roof mutations affect the stability of the mCD1d-
iNKT cell TCR complex. (A) Binding response of a Va14Vb8.2 TCR to
immobilized mouse CD1d loaded with a-GalCer as measured by surface
plasmon resonance. Binding of increasing concentrations of the TCR is
shown for each mutant as black lines. (B) Kinetic parameters measured
for WT and mutants proteins.
doi:10.1371/journal.pbio.1001189.g006
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to induce conformational changes on both the Glc-DAG-s2 ligand
and mCD1d (Figures 2 and 5A), which result in a conserved
binding mode, as well as a weaker affinity, typical of the DAG
antigens compared to their glycosphingolipid counterparts [14,22].
However, due to the presence of glucose, with a different
conformation of its 49 hydroxyl group compared to galactose, a
hydrogen bond with the CDR1a of the TCR is lost, while a new
contact with Gly155 on the a2 helix of CD1d is formed. While this
alteration does not translate to an overall change in TCR affinity
at equilibrium, it has profound effects on the kinetics of binding of
the antigen complex with mCD1d by the iNKT cell TCR.
Previous studies showed that contacts between the ligand and the
TCR dominate the initial association phase, while protein-protein
(and ligand-protein) contacts affect the stability of the complex [9].
Therefore, the loss of a contact with the a chain of the TCR can
account for the slower TCR association rate exhibited by this
ligand. Interestingly, the iNKT TCR appears to be especially
sensitive to the conformation of the 49-OH group, with glucose-
containing antigens showing generally reduced potency (in terms
of cytokine release by iNKT cells) [9,10] and preferential
proliferation of Vb7+ cells [10] compared to a-GalCer. Further-
more, the consequent locking of the glucose head in the favorable
position following TCR engagement, described here for Glc-
DAG-s2, likely contributes to a slower dissociation. These novel
contacts rely on the presence of both the vaccenic acid and
glucose, as the variants with an oleic acid in place of the vaccenic
acid, or a galactose replacing the glucose, are considerably less
active. Consistent with this, a model of Gal-DAG-s2 suggests that
the presence of an axial 49 hydroxyl would be located in an
unfavorable position for recognition by the iNKT TCR (Figure
S2). Moreover, the antigenicity of the ligand requires vaccenic acid
to be in the sn-2 position of the ligand in order to orient correctly
the glucose for recognition by the TCR. Interestingly, these
structural requirements do not appear to be influenced by the
variable CDR3b loop, as three different hybridomas responded to
Glc-DAG-s2 at comparable levels (Figure 5C).
Glc-DAG-s2 also stimulates human iNKT cells [8] but is not
clear whether the same stringent requirements observed in mouse
are conserved in the human CD1d-TCR interaction as no
structural information is available on the modality of recognition
of DAG antigens by the human iNKT TCR. Clearly, more work
has to be done to illuminate the structural basis of microbial DAG
recognition by human iNKT cells.
Consistent with a model in which the TCR contacts first the
ligand and subsequently CD1d, our mutational data also show that
the protein-protein interface above the F9 pocket is critical for the
interaction, and specifically, that this region determines the
dissociation rate, and therefore the stability, of the mCD1d-
TCR complex (Figure 6). Interestingly, the mechanism of antigen
recognition by the iNKT TCR appears to be radically different to
what has been observed for MHC-TCR interactions, where the
TCR first contacts residues on the antigen presenting molecule
and only a later stage contacts the antigen itself [23].
The extensive amount of structural and biochemical informa-
tion recently collected on the interaction between CD1d and the
iNKT TCR is consistent with the idea of the iNKT TCR as a
pattern recognition receptor [10,12–14,18]. While the S. pneumo-
niae antigen follows the typical pattern of an a-linked sugar to a
diacyl backbone, the data presented here show clearly that, within
this pattern, stringent requirements are still in place. In particular,
the Glc-DAG-s2 ligand exemplifies the case of a relatively weak
hexose and an uncommon alkyl chain synergistically contributing
to the potency of an iNKT antigen.
Materials and Methods
Protein Expression and Purification
The expression and purification methods of fully glycosylated
mouse CD1d/b2m heterodimer proteins were reported previously
[11]. Mouse TCR refolding was performed according to
previously reported protocols [14] with minor modifications. 64
mg of a chain and 96 mg of b chain inclusion bodies were mixed
together and added drop wise to 1 L refolding buffer (50 mM
Tris-HCl, 0.4 M L-arginine, 5 M urea, 2 mM EDTA, 5 mM
reduced glutathione, 0.5 mM oxidized glutathione, 0.2 mM
PMSF, pH 8.0 at RT) two times. The refolding mix was dialyzed
twice against 18 L dialysis buffer 1 (10 mM Tris-HCL, 0.1 M
urea, pH 8.0) for 16 h and then once against 18 L of 10 mM Tris-
HCl pH 8.0 for 24 h. The refolded TCR proteins were purified by
MonoQ 5/50 GL (GE Healthcare) using a linear NaCl gradient
(0–300 mM NaCl) followed by size exclusion chromatography
using a Superdex S200 10/300 GL (GE Healthcare) in 50 mM
Hepes pH 7.5, 150 mM NaCl.
Glycolipid Loading and Ternary Complex Formation
The synthetic DAG ligand Glc-DAG-s2 was synthesized as
previously reported [8] and dissolved at 4 mg/ml in DMSO.
mCD1d was incubated overnight with 3–6 molar excess of Glc-
DAG-s2 in presence of 0.05% Tween-20 and 100 mM Tris-Cl
pH 7.0. Glc-DAG-s2 loaded CD1d was purified by size exclusion
chromatography first and then incubated with equimolar amount
of TCR for 30 min without further purification. The complex was
concentrated to 4.8 mg/ml for crystallization.
Crystallization and Structure Determination
Crystals of mCD1d-Glc-DAG-s2-TCR complexes were grown
at 22.3uC by sitting drop vapor diffusion while mixing 0.5 ml
protein with 0.5 ml precipitate (17% polyethylene glycol 3350, 8%
v/v Tacsimate pH 5.0). Crystals were flash-cooled at 100 K in
mother liquor containing 20% glycerol. Diffraction data were
collected at the Stanford Synchrotron Radiation Laboratory
(SSRL) beamline 7.1 and processed with the iMosflm software
[24]. The mCD1d-Glc-DAG-s2-TCR crystal belongs to space
group C2221 with cell parameters a=78.1 A ˚; b=190.7 A ˚; c=
150.9 A ˚. The asymmetric unit contains one mCD1d-glycolipid-
TCR molecule with an estimated solvent content of 55.0%. The
structures were determined by molecular replacement using
MOLREP as part of the CCP4 suite [25,26] using the protein
coordinates from the mCD1d-iGb3 structure (PDB code 2Q7Y)
[27], followed by the Va14Vb8.2 TCR [14] (from PDB code
3O8X) as the search model. When a MR solution containing both
mCD1d and TCR was obtained, the model was rebuilt into sA-
weighted 2Fo–Fc and Fo–Fc difference electron density maps using
the program COOT [28]. Maximum-likelihood restrained
refinement coupled with TLS refinement was performed in
REFMAC [29] with five anisotropic domains (a1-a2 domain of
CD1d, including carbohydrates and glycolipid, a3-domain, b2m,
variable domains and constant domains of the TCR). The quality
of the model was evaluated with the program Molprobity [30] and
the validation tools available in COOT. Shake-omit maps were
generated by removing the ligand from the structure and
randomly perturbating the coordinates, occupancy, and B-factor
of each atom by 0.2 A ˚, 0.05 units, and 20 A ˚ 2, respectively, with
the software Moleman2 [31]. The resulting structure was then
refined with the software REFMAC as described earlier. Data
collection and refinement statistics are presented in Table 1.
Coordinates and structure factors have been deposited in the
Protein Data Bank under accession code 3TA3.
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Mouse CD1d mutants were generated using Quick Change II
Site-Directed Mutagenesis Kit (Stratagene, Agilent Technologies)
according to the manufacturer’s instructions with the primers
indicated below. Mutated constructs were purified with the
Qiagen Miniprep Kit (Qiagen) and the presence of the mutation
confirmed by sequencing. The mutated birA-tag mCD1d/b2m
were expressed and purified using the same method described
above for mCD1d/b2m.
Primer sequences: L84V 59-ttaccagggacatacaggaagtagtcaaaat-
gatgtcacc-39; L84V_antisense 39-aatggtccctgtatgtccttcatcagttttacta-
cagtgg-59; L84F 59-accagggacatacaggaattcgtcaaaatgatgtcacc-39;
L84F_antisense 39-tggtccctgtatgtccttaagcagttttactacagtgg-59;V 1 4 9 L
59-cttggttagacttgcccatcaaattgctcaacgctg-39; V149L_antisense 39-ga-
accaatctgaacgggtagtttaacgagttgcgac-59; L150V 59-cttgcccatcaaagtg-
gtcaacgctgatcaagg-39; L150V_antisense 39-gaacgggtagtttcaccagttgc-
gactagttcc-59;M 6 9 A5 9-gtgggagaagttgcagcatgcgtttcaagtctatcgagtc-39;
M69A_antisense 39-gtgggagaagttgcagcatgcgtttcaagtctatcgagtc-59;M162A
59-caagtgcaaccgtgcaggcgctcctgaatgacacct-39; M162A_antisense 39-
caagtgcaaccgtgcaggcgctcctgaatgacacct-59.
Cell Lines and Culture Conditions
A20/CD1d cells are derived from murine B cell lymphoma A20
(American Type Culture Collection, Rockville, MD), with stable
expression of wild type mouse CD1d [7,32]. A20/CD1d and
iNKT hybridomas cell lines Hy2C12, Hy1.2, and Hy1.4 were
cultured in RPMI 1640 medium supplemented with 2 mM L-
glutamine, 100 mg/ml each of penicillin and streptomycin,
50 mM 2-mercaptoethanol, and 10% FBS.
A20 Lipid Antigen Presentation Assay
Mouse iNKT cell hybridoma 1.2 (Va14/Vb8.2) has been
described previously [3,6]. 1610
6 A20/CD1d cells expressing
wild-type mCD1d were cultured in complete medium containing
indicated amounts of lipid antigens or vehicle (56 mg/ml sucrose,
7.5 mg/ml histidine, and 5 mg/ml Tween-20 [pH 7.2]) overnight.
On the second day of culture, A20/CD1d were collected, washed
thoroughly, and 1610
5 APCs were seeded in the presence of
5610
4 iNKT cell hybridomas per well in a 96-well plate for 24 h,
and IL-2 in the supernatant was measured by ELISA according to
the manufacturer’s instructions (BD Biosciences).
APC Free Antigen Presentation Assay
Stimulation of mouse iNKT cell hybridomas on microwell
plates coated with soluble mCD1d was carried out according to
published protocols [3,6,33], with a few modifications. Briefly, the
indicated amounts of compounds were incubated for 24 h in
microwells that had been coated with 1.0 mg of mCD1d. After
washing, 5610
4 iNKT cell hybridoma cells were cultured on the
plate for 16 h, and IL-2 in the supernatant was measured by
ELISA according to the manufacturer’s instructions (R&D
systems).
Surface Plasmon Resonance
Surface Plasmon Resonance studies using a refolded and
biotinylated Va14Vb8.2 TCR were carried out as previously
reported [11] with 300–500 response units (RU) of biotinylated
mCD1d-vehicle or mCD1d-ligand immobilized on the chip. Serial
dilutions of Va14Vb8.2 were injected with increasing concentra-
tions (0.002–1.25 mM) over a streptavidin CAPture chip (GE
Healthcare). The experiment was performed twice. Loading
efficiency was measured by immobilizing the biotinylated
mCD1d-ligand (after incubation for 16 h in the presence of
1 mg/ml of a-GalCer) complex on a CAPture chip (400–500 RU)
followed by the injection of a saturating concentration (1 mM) of
the Fab portion of the mCD1d-a-GalCer specific antibody L363
[20]. 100% glycolipid loading efficiency is achieved when the
increase in RU upon Fab binding is equal to the RU of CD1d-
glycolipid coated on the chip, as mCD1d-glycolipid and Fab have
a comparable molecular weight.
Supporting Information
Figure S1 Shake omit map of the Glc-DAG-s2 ligand. Side (A)
and top (B) view of the mCD1d binding groove with the ligand in
yellow. A shake-omit Fo-Fc map contoured at 2s is shown as a
green mesh around the ligand.
(TIF)
Figure S2 Modeling of Gal-DAG-s2 in the ternary complex.
Detailed view of the Gal-DAG-s2 ligand at the mCD1d-TCR
interface with the ligand in green, mCD1d in grey, and the iNKT
TCR a chain in cyan. The different position of the 49-OH group
for Glc-DAG-s2 is shown in yellow for comparison. Distances
between the 49-OH group of the antigen and Asn30a on the TCR
and Gly155 on mCD1d are shown as dashed lines with the
corresponding length expressed in A ˚.
(TIF)
Table S1 Molecular contacts in the TCR complex. The
program CONTACT [26] was used to analyze the molecular
interactions within the complexes. Cutoffs of 4 A ˚ (van der Waals
interactions), 3.5 A ˚ (hydrogen bonds), and 4.5 A ˚ (salt bridges) were
applied.
(DOC)
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